M PIMAVANSERIN (is an active metabolite) | PIMAVANSERIN | ATC N05AX17
NERVOUS SYSTEM ANTIPSYCHOTIC TREATMENT OF HALLUCINATIONS AND DELUSIONS ASSOCIATED WITH PARKINSON'S DISEASE PSYCHOSIS INVERSE AGONIST / ANTAGONIST SEROTONIN 5-HT2A (KI = 0.087 NANOMOLAR) AND 5-HT2C (KI = 0.44 NANOMOLAR) SIGMA 1 RECEPTOR (KI = 120 NANOMOLAR) | - | HT 200 HOUR | 5-HT2A RECEPTOR 5-HT2C RECEPTOR | 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |